SCHEMBL7839346

SCHEMBL7839346

COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1NCC=CC(=O)N1CCOC(=O)C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 13/20 0.58
▸ EPHA2 P29317 2/20 0.52
▸ KDR P35968 6/20 0.50
▸ ERBB2 P04626 3/20 0.50
▸ FBP1 P09467 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ GAK O14976 1/20 0.50
▸ MAPK13 O15264 1/20 0.50
▸ ABL1 P00519 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CDK1 P06493 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ SRC P12931 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ EPHB2 P29323 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7849876 0.85 EPHA2 (0.56) EGFREPHA2KDRERBB2FBP1
SCHEMBL7852031 0.83 EGFR (0.63) EGFRKDRERBB2FBP1KDM4E
SCHEMBL7847659 0.82 EGFR (0.60) EGFRKDRERBB2FBP1KDM4E
SCHEMBL1418072 0.82 EGFR (0.63) EGFRERBB2GAKSRCERBB4
SCHEMBL1418070 0.82 EGFR (0.63) EGFRERBB2GAKSRCERBB4
SCHEMBL7839286 0.82 EGFR (0.61) EGFRKDRERBB2FBP1KDM4E
SCHEMBL7839969 0.82 EGFR (0.59) EGFREPHA2KDRERBB2FBP1
SCHEMBL7848643 0.80 EGFR (0.56) EGFREPHA2KDRERBB2FBP1
SCHEMBL7847631 0.78 EGFR (0.57) EGFRKDRERBB2FBP1KDM4E
SCHEMBL7848404 0.78 EGFR (0.59) EGFRKDRERBB2FBP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1157011-A1 4-AMINO- QUINAZOLINE AND QUINOLINE DERIVATIVES HAVING AN INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES Boehringer Ingelheim Pharma KG (DE) 2001-11-28 — — EP disclosed
WO-2000051991-A1 4-AMINO-QUINAZOLINE AND QUINOLINE DERIVATIVES HAVING AN INHIBITORY EFFECT ON SIGNAL TRANsSDUCTION MEDIATED BY TYROSINE KINASES BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-09-08 — — WO disclosed
Send feedback